Catalyst Wire Dossier Catalyst Wire Dossier

Dimolegin

dimolegin · Avexima Diol LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Dimolegin, covering 2022-01-11 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin [Phase 3]

See pricing